Evaluation of the pharmacokinetics and pharmacodynamics of two leuprolide acetate 45 mg 6-month depot formulations in patients with prostate cancer
Author:
Affiliation:
1. Pharmaceutical Development; AbbVie Inc.; North Chicago IL USA
2. South Orange County Medical Research Center; Laguna Hills CA USA
Funder
AbbVie Inc.
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Reference14 articles.
1. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference;Roach;Int J Radiat Oncol Biol Phys.,2006
2. Performance status assessment in cancer patients;Conill;Cancer.,1990
3. An update on androgen deprivation therapy for prostate cancer;Sharifi;Endocr Relat Cancer.,2010
4. An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer;Sartor;Urology.,2003
5. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders;Plosker;Drugs.,1994
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-acting injectable formulation technologies: challenges and opportunities for the delivery of fragile molecules;Expert Opinion on Drug Delivery;2022-07-28
2. Advances in encapsulating gonadotropin-releasing hormone agonists for controlled release: a review;Journal of Microencapsulation;2022-07-04
3. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of EUFEPS/AAPS fourth conference;European Journal of Pharmaceutical Sciences;2021-12
4. Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer;Expert Opinion on Pharmacotherapy;2016-11-28
5. A Semi-Mechanistic Integrated Pharmacokinetic/Pharmacodynamic Model of the Testosterone Effects of the Gonadotropin-Releasing Hormone Agonist Leuprolide in Prostate Cancer Patients;Clinical Pharmacokinetics;2015-03-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3